Viking Therapeutics, Inc
VKTX
$25.17
-8.04%
VKTX
Viking Therapeutics, Inc
$25.17
VKTX price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Viking Therapeutics, Inc's 12-month outlook, with a consensus price target around $94.50 and implied upside of +275.4% versus the current price.
Average Target
$94.50
0 analysts
Implied Upside
+275.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$38 - $125
Analyst target range
Drowning in data?
Find the real signal!
VKTX Technical Analysis
Beta
0.65
0.65x market volatility
Max Drawdown
-40.3%
Largest decline past year
52-Week Range
$25-$43
Price range past year
Annual Return
-27.5%
Cumulative gain past year
| Period | VKTX Return | S&P 500 |
|---|---|---|
| 1m | -14.7% | +0.2% |
| 3m | -32.1% | +2.9% |
| 6m | -28.5% | +8.4% |
| 1y | -27.5% | +14.9% |
| ytd | -28.9% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
VKTX Fundamental Analysis
Quarterly Revenue
$0.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$-418441000.0B
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is VKTX Overvalued?
PE
-11.0x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-10.6x
Enterprise Value Multiple
